We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28.
- Authors
Mamounas, Eleftherios P; Bryant, John; Lembersky, Barry; Fehrenbacher, Louis; Sedlacek, Scot M; Fisher, Bernard; Wickerham, D Lawrence; Yothers, Greg; Soran, Atilla; Wolmark, Norman
- Abstract
The primary aim of National Surgical Adjuvant Breast and Bowel Project (NSABP) B-28 was to determine whether four cycles of adjuvant paclitaxel (PTX) after four cycles of adjuvant doxorubicin/cyclophosphamide (AC) will prolong disease-free survival (DFS) and overall survival (OS) compared with four cycles of AC alone in patients with resected operable breast cancer and histologically positive axillary nodes.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 16, p3686
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.10.517